Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

Université Laval

$17,500.00

Nanoparticles to understand and treat vascular calcification in chronic kidney disease

EF 2019-20

Résumé
"Patients with chronic kidney disease (CKD) frequently develop heart problems and are prone to strokes. These events occur when blood vessels stiffen, often caused by the presence of an abundance of calcium. Medial vascular calcification involves transdifferentiation of vascular smooth muscle cells (VSMC) into osteoblast-like cells. This is characterized by the presence of hydroxyapatite deposits, the major component of bone mineral and its matrix. There is currently no treatment that specifically targets vascular calcification. To address this gap, we developed tetracycline-functionalized nanoparticles to target vascular calcification. These novel compounds are composed of a polymer core, a fluorochrome, and a tetracycline-decorated surface. This antibiotic is known to have a high affinity for hydroxyapatite deposits, and therefore calcification sites. Our preliminary results showed that these nanoparticles are stable and can specifically target areas of vascular calcification both in vitro and in vivo. For this proposal, our hypothesis is that these nanoparticles can be used to target and modulate key pathways involved in vascular calcification development. The objectives of this proposal are to use these nanoparticles to 1) target and understand vascular calcification mechanisms, and 2) bind relevant active compounds that could potentially prevent or reverse vascular calcification. The significance of this unique research proposal is to add new knowledge in our understanding of the mechanisms of vascular calcification in CKD while also generating potential innovative therapies to treat vascular calcification in CKD."
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
428766
Name
Cull Olivia
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Nanoparticles to understand and treat vascular calcification in chronic kidney disease
Programtype2
Studentship Programs
Orgnameinp2
Université Laval
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Animal Models; Aorta; Cardiovascular Disease; Cell Biology; Chronic Kidney Disease; Nanoparticles; Vascular Calcification; Vascular Smooth Muscle
Abstract
"Patients with chronic kidney disease (CKD) frequently develop heart problems and are prone to strokes. These events occur when blood vessels stiffen, often caused by the presence of an abundance of calcium. Medial vascular calcification involves transdifferentiation of vascular smooth muscle cells (VSMC) into osteoblast-like cells. This is characterized by the presence of hydroxyapatite deposits, the major component of bone mineral and its matrix. There is currently no treatment that specifically targets vascular calcification. To address this gap, we developed tetracycline-functionalized nanoparticles to target vascular calcification. These novel compounds are composed of a polymer core, a fluorochrome, and a tetracycline-decorated surface. This antibiotic is known to have a high affinity for hydroxyapatite deposits, and therefore calcification sites. Our preliminary results showed that these nanoparticles are stable and can specifically target areas of vascular calcification both<em> in vitro</em> and <em>in vivo</em>. For this proposal, our hypothesis is that these nanoparticles can be used to target and modulate key pathways involved in vascular calcification development. The objectives of this proposal are to use these nanoparticles to 1) target and understand vascular calcification mechanisms, and 2) bind relevant active compounds that could potentially prevent or reverse vascular calcification. The significance of this unique research proposal is to add new knowledge in our understanding of the mechanisms of vascular calcification in CKD while also generating potential innovative therapies to treat vascular calcification in CKD."
Competitiondate
201912
Approvedterm2
1 yr 0 mth
Pinamesdelim
Cull, Olivia
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~